Replies to post #207632 on Elite Pharmaceuticals Inc (ELTP)

[hyder]

WeeZuhl, you have convinced me with your argument that we should go forward with Eli-202 and if I were NH I would hire you to move this forward. Keep up with your exceptional DD on ELTP.

[Couch]

Solid post to say the least! My suggestion is to send this post to Dianne and ring her on the matter a few days thereafter. Put this post in the hands on Nasrat.

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: [phone]
Email: [e-mail]

[NASDAQ2020]

As opiod/naltrexone ADFs take over the market, abusers may gravitate toward opiod/APAPs .
They should be removed in the future or have naltrexone added.
APAP containing opiods must not be a priority with the FDA, but they will have to be addressed in the future.

Enjoyed the post, have a good weekend.